CANCER
PROGRAM
Of Southeastern Med
presents
the
2007 Cancer Program Annual Report
with Statistical Data from 2006
Southeastern Med
1341 Clark Street
Cambridge, Ohio 43725
Southeastern Med
Cancer
Committee
2006
Michael Sarap, MD James W. Keller,
MD
Chairman, Surgery President &
CEO/CMO
Clifford Maximo, MD Becky Wheeler,
CTR
Urology Cancer
Registry
Andrew
Eddy, MD Bonnie Burns
Vice
President Medical Affairs ACS Cancer Control
Specialist
Charles Muchnok, MD Kelli Wehr
Radiology & Nuclear Medicine Radiation
Therapist
Cambridge Regional Cancer
Eyad
Mahayri, MD Center
Internal Medicine
Robert L. Chess, MD Gail Sims, LPN,
MT
Pathology & Clinical Pathology Nursing
Srini Vasan, MD Leigh Anne Hehr
Radiation Oncology ACS Colorectal
Initiative
Nik
Shah, MD David Finn, R.Ph
Oncology/Hematology
Director Pharmacy
Renee
Shalosky, RN, MSN, CPHQ
Director Quality Improvement
Sandy Black, RN, OCN
Nursing
Bev
Peeper, RNC
Nursing
Nancy Neff, LSW, BSW, CCM
Quality Care Management
INTRODUCTON
The goal
of the Southeastern Med cancer program is to provide quality care
for cancer patients and their families as well as decrease the
morbidity and mortality of patients with cancer. Such a goal cannot
be met by any one individual, but through the collective efforts of
many. Those actively involved in helping our cancer patients,
include physicians, nurses, social workers, hospital support staff,
management, hospital volunteers, clergy and community support groups
including the American Cancer Society and Hospice of Guernsey.
Through the combined work of these groups, the care and support of
cancer patients and their families is improved.
The
Southeastern Med Cancer Program is approved by the American College
of Surgeons, Commission on Cancer, and is committed to the
commission’s standards of performance, improvement, outcome
measurements, cost-effectiveness and collaboration with physicians
and other health care service agencies.
This
annual report summarizes the Cancer Program’s experience with the
statistical data for 2006.
Southeastern Ohio Regional Medical Center is pleased to present our
2007 Annual Report.
REPORT FROM THE CHAIRMAN…..
Southeastern Ohio Regional Medical Center would like to share with
you it’s Cancer Program’s Annual report for the calendar year of
2006. Our Cancer Program has had a busy and productive year in 2006.
Our commitment to continually improve the quality of care for the
cancer patient was demonstrated by our continued achievements.
v
Implemented LAB OUTREACH program with the Cambridge Regional Cancer
Center, providing outpatient phlebotomy services for oncology
patients.
v
Implemented chemotherapy protocols for several chemo medications
after approved by Pharmacy Committee.
v
Initiated phone contacts within 24 hours of therapy for ASA patients
to assess tolerance and side effects of treatment.
v
Collaboration with Southeastern Med and American Cancer Society
continued to provide a Patient Navigator Program to help patients,
families, & caregivers navigate the systems needed during the cancer
journey serving 45 patients during 2006.
v
Continued the “Tar Wars” tobacco education program in the schools,
making 29 presentations and reaching 700 children.
v
Collaborated with American Cancer Society and the Ohio Department of
Health to hold the Second Colon Cancer Summit on October 11th,
2006. Efforts revealed: Increased colorectal screening by 34% in one
year, 10% increase in polyp removal & total # of colorectal cancer
diagnosis has risen 33% since formation of the team.
v
Held
three Look Good Feel Better classes reaching 15 participants.
v
Continued to offer Freshstart Smoking Cessation classes.
v
Distributed colon-screening kits at numerous health fairs as well as
Byesville Pharmacy & Northstar Pharmacy.
v
Participated in the Older Adult Health Fair offering skin cancer
screening and oral screening.
v
Collaborated with ACS, Cambridge Regional Cancer Center, and
Guernsey County Cancer Society to offer Cancer Survivors Day
Celebration on June 4th with 78 cancer survivors
attending.
v
Participated in the annual Children’s Health Fair offering tobacco
education.
v
Participated in Relay For Life on June 23rd & 24th
.
v
Provided
a community educational luncheon “Advances in Breast Cancer
Prevention, Detection & Diagnostic Procedures” with speakers Dr.
Sarap & Dr. Eke with over 60 in attendance on October 27, 2006.
v
Coordinated a program with Genesis Cancer Services called “Reducing
Cervical Cancer in Appalachia Ohio” on November 7th, 2006
with 30 in attendance.
v
Provided
Pain Management Breakfast In-service for physicians on September 20th,
2006.
v
Provided
professional education in-service on Chemo Induced Nausea & Vomiting
for physicians and other healthcare professionals on March 22, 2006.
v
Offered
“Cancer & Nutrition” presentation on March 28, 2006 in association
with churches.
v
Piloted
“Blue Sticky Note” Project with physicians to remind them to discuss
colon cancer with their patients.
v
Colorectal Task Force received grants from the American Cancer
Society & Kiwanis Foundation to continue educational efforts.
The
Cancer Committee continued our commitment to excellence in Oncology
care emphasizing the involvement of the community, and the primary
care physicians on the care of the patient with cancer, as well as
making available the most advance treatment of our patients.
It is
with great pleasure that we present the Southeastern Med 2006 Cancer
Program Annual Report.
Michael
Sarap, MD
Cancer Committee
Chairman
CANCER REGISTRY
The
Cancer Registry is the cancer data center for Southeastern Med. The
mission of the Cancer Registry is to encourage systematic lifetime
re-examination of all cancer patients and to provide statistics on
collected data to staff physicians for research and educational
evaluation. The primary goal of the Registry is to monitor all types
of cancer diagnosed and/or treated at Southeastern Med. The
maintenance and collection of accurate data is also a useful tool
for administrative planning of hospital resources and staff.
Established in January, 1985 the data base is maintained by a
Certified Cancer Registrar who collects cancer management data and
annually follows every living patient in the registry. She is not
only responsible for data collection but other activities which
include planning all meetings with the Cancer Committee; planning
and recording necessary documentation of monthly Cancer Conferences;
preparing all Patient Care Evaluation Studies.
The
Cancer Registry uses a data system called Precis Hospital which is
designed to collect, manage, and analyze data on patients with all
types of cancer. Included in the database are every inpatient and
outpatient diagnosed and/or treated at Southeastern Med. The data is
then reported to national, and state agencies, who will help
determine the most successful treatment options available to cancer
patients in the future. These agencies are:
The
Ohio Cancer Incidence Surveillance System (OCISS)
The
National Cancer Data Base
Much
of the aggregate information is published in local, state and
national reports, such as the American Cancer Society Facts and
Figures.
The
Commission on Cancer designs Patient Care Evaluations (PCEs) to be
completed by the Cancer Registrar and a member of the Cancer
Committee. Patient Care Evaluation studies are nationwide studies of
malignant diseases that are designed
to
describe the practice of medicine at the community level and to
provide management and patient survival information.
It is
the purpose of the registry to provide information to interested
qualified parties as part of the service of the department. Requests
should be directed to Becky Wheeler, CTR from 6 a.m. to 2:30 p.m.
daily.
Annual
lifetime follow-up of former patients is a very important part of
the program. This is accomplished through letters to the attending
physician or by letters or phone calls to patients and/or family
members. The registry serves as a reminder to former patients to
continue their follow-up exams with a physician. Currently
approximately 1062 patients are in active follow-up maintaining 95%
follow-up rate.
A
total of 226 new cases were accessioned into the registry at
Southeastern Med during 2006. A total of 4288 new cancer cases have
been entered into the registry since January 1, 1985.
If you
have questions about the Cancer Registry, need referral information
or have questions about a cancer diagnosis, please feel free to call
Becky Wheeler, CTR, Cancer Registrar at (740) 439-8156.
CANCER CONFERENCE
The
Cancer Conference (Tumor Board Conference) is a multidisciplinary
conference held monthly at Southeastern Med. This conference
provides a forum for coordinating cancer care. The meeting serves to
improve patient care by providing educational credits to all
physicians, as well as other health care professionals attending the
conference. Cancer Conferences are arranged and documented by the
Cancer Registry staff and are scheduled the second Thursday of each
month in the North Tower Conference Room.
Total
number on conference in 2006 12
Total
number of cases presented 79
Total
number of prospective cases presented 71 (90%)
The
Mid-Ohio Valley continuing education designates our Cancer
Conferences for one (1) credit hour in Category 1 for Physician
Recognition Aware of the American Medical Association.
SUMMARY OF 2006 CANCER
CASES
Incidence
According the Ohio Cancer Facts & Figures 2006 published by the
American Cancer Society, the projected incidence for cancer in Ohio
is 55,813 new cases. The registry staff abstracted a total of 226
cancer cases during 2006. Of those 207 were analytic and 19 were
non-analytic cases, of which 13 were prostate cases diagnosed &
treated in a physician office.
The
four most commonly diagnosed cancer sites at Southeastern Med in
2006 were breast with 52 cases (25%), colon/rectum with 40 cases
(19%), lung with 30 cases (14%), and prostate with 17 cases (8%).
This is illustrated graphically below.
|
SITE |
# CASES |
% Southeastern Med |
|
Breast |
52 |
25% |
|
Colon/Rectum |
39 |
19% |
|
Lung |
30 |
14% |
|
Prostate |
17 |
8% |
|
All Others |
69 |
33% |
Note: An additional 13 cases of prostate
cancer were diagnosed & treated in a physician
office and considered non-analytical and not
included in this graph.
A
comparison of the sites with the National and State statistics is
shown below.
|
SITE |
Southeastern Med % |
US% * |
OHIO% * |
|
Breast |
25% |
15% |
16% |
|
Colon/Rectum |
19% |
11% |
11% |
|
Lung |
14% |
12% |
13% |
|
Prostate |
8% |
17% |
15% |
* Based on information from
ACS Cancer Facts & Figures 2006.
Age
The
incidence of cancer increases with age. In 2006, 207 (65%) of the
cases diagnosed were between 60 and 89 years of age. Mean age was
66.2 years. A graph below illustrates aged distribution at
diagnosis.
AGE
|
Southeastern Med %
|
|
0-39 |
2% |
|
40-49 |
8% |
|
50-59 |
16% |
|
60-69 |
26% |
|
70-79 |
30% |
|
80-89 |
17% |
Sex
Males
accounted for 83 cases (41%) and females accounted for 119 cases
(59%) in 2006.
County at Diagnosis:
As you
can see from the graph below, 82% of all cases diagnosed at
Southeastern Med reside in Guernsey County. 8% of the patients
reside in Noble County and several other surrounding counties make
up the rest of the cases.
|
COUNTY AT
DIAGNOSIS |
# CASES |
% SOUTHEASTERN
MED |
|
Guernsey County |
170 |
82% |
|
Noble County |
17 |
8% |
|
Tuscarawas County |
8 |
4% |
|
Muskingum County |
8 |
4% |
|
Belmont County |
2 |
1% |
|
Coshocton County |
2 |
1% |
Stage at Diagnosis
Referring to the Table below, it can be seen that 21 cases (10%)
were diagnosed in Stage 0 ( In Situ), 59 cases (29%) were diagnosed
in Stage I, 39 cases (19%) were diagnosed in Stage II, 26 cases
(13%) diagnosed in Stage III and 27 cases (13%) in stage IV. 35
cases (16%) were either unknown or unstaged.
|
STAGE |
SEORMC% |
|
Stage 0 (In Situ) |
10% |
|
Stage I |
29% |
Stage II
|
19% |
|
Stage III |
13% |
|
Stage IV |
13% |
|
Unknown/Unstagable Stage |
16% |
PRIMARY SITE ANALYSIS
COLORECTAL CANCER
Michael Sarap, M.D.
Screening tests offer a powerful opportunity for the
prevention, early detection, and successful treatment of colorectal
cancers. Yet, fewer than 45% of Americans 50 and older have had a
sigmoidoscopy or colonoscopy in the past five years. While people
cannot change their genetic makeup or family health history, most
people can reduce their risk of colorectal cancer by following
screening guidelines; eating a healthy, low-fat diet; and increasing
their level of physical activity.
Nationally, an estimated 106,680 colon and 41,930 rectal cancer
cases occurred in 2006. Colorectal cancer is the third most common
cancer both in men and women. The incidence rate declined marginally
by almost 2% per year during the period 1998 – 2002. Research
suggests that these declines may be in part due to increased
screening and polyp removal, preventing progression of polyps to
invasive cancers.
The risk of developing colorectal cancer increases with
age. In Ohio, between 1999 and 2003, approximately 93% of
individuals who developed colorectal cancer were 50 and over.
Currently, a man living in the United States has a 1 in 24 lifetime
risk of developing invasive colorectal cancer, and a woman has a 1
in 29 lifetime risk of developing invasive colorectal cancer.
An estimated 55,170 colorectal cancer deaths occurred in
2006 nationally, accounting for about 10% of cancer deaths. The
mortality rate continued to decline for both men and women over the
past two decades, at an average of 1.8% per year.
Surgery is the most common form of treatment for
colorectal cancer. For cancers that have not spread, it is
frequently a cure. Chemotherapy or chemotherapy plus radiation is
given before or after surgery to most patients whose cancer has
deeply penetrated the bowel wall or has spread to the lymph nodes. A
permanent colostomy (creation of an abdominal opening for
elimination of body wastes) is very rarely needed for colon cancer
and is infrequently required for rectal cancer.
At Southeastern Med most new colorectal cancer cases are discussed
at a multidisciplinary cancer conference to assure there is a
consensus amongst caregivers in regard to the treatment plan.
Following you will see a breakdown of the data for
colorectal cancer diagnosed at Southeastern Med from 2002 – 2006.
This includes case distribution by year, age & sex distribution,
class of case, county at diagnosis, stage at diagnosis, first course
of treatment, and observed survival rate by stage.
CASE DISTRIBUTION BY
YEAR
Between 2002 and 2006 there were 154 new cases of
colorectal cancer diagnosed at Southeastern Med. A graph below shows
the breakdown by year.
|
Year
of Diagnosis |
# Of
Cases |
% Of
Cases |
|
2002 |
30 |
19.48% |
|
2003 |
30 |
19.48% |
|
2004 |
27 |
17.53% |
|
2005 |
27 |
17.53% |
|
2006 |
40 |
25.97% |
|
Total |
154 |
100.00% |
AGE DISTRIBUTION
The
total number of Southeastern Med colorectal cancer cases between
2002 and 2006 is 154. The age distribution is listed below.
|
AGE |
Southeastern Med % |
|
0-39 |
.65% |
|
40-49 |
4.55% |
|
50-59 |
11.69% |
|
60-69 |
26.63% |
|
70-79 |
35.72% |
|
80+ |
20.78% |
SEX DISTRIBUTION
Of the
154 cases of colorectal cancer diagnosed between 2002 and 2006,
47.68% were female and 52.32% were male.
CLASS OF CASE
Class of
case tells us where the patient was diagnosed and treated. Between
2002 and 2006 we found that 95% of the colorectal cancer patients
were diagnosed and treated here at Southeastern Med. We found that
3% were diagnosed here and treated elsewhere and 2% were diagnosed
elsewhere and first course of treatment performed at Southeastern
Med. Thanks to our excellent physicians and treatment center,
patients can be treated here at home.
COUNTY AT DIAGNOSIS
Below is
a graph, which shows county at diagnosis for our colorectal cancer
patients, found between 2002 and 2006. As you can see 79% of our
colorectal cancer patients reside in Guernsey County.
|
County a Diagnosis |
# Cases |
% Southeastern Med |
|
Guernsey County |
121 |
78.57% |
|
Noble County |
15 |
9.74% |
|
Tuscarawas County |
8 |
5.19% |
|
Muskingum County |
7 |
4.55% |
|
Belmont County |
2 |
1.30% |
|
Monroe County |
1 |
0.65% |
STAGE AT DIAGNOSIS
Nearly
all colorectal cancers can be treated successfully if detected
early. As you can see in the graph below, 27% of our colorectal
cancer cases were found in early stages (Stage 0 In situ & Stage I).
Only 14% were found in Stage IV (metastatic disease).
|
AJCC Stage Group |
# Cases |
% Cases SEORMC |
% Cases National |
|
Stage 0 |
5 |
3.25% |
7.31% |
|
Stage I |
| |